Kiora Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Accrued Expenses

Accrued Expenses

3 Months Ended

12 Months Ended

Mar. 31, 2015

Dec. 31, 2014

Accrued Liabilities [Abstract]

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

4. Accrued Expenses

Accrued expenses consist of the following:


		March 31, 2015 (Unaudited)				December 31, 2014
Payroll and benefits		$	36,301			$	168,269
Clinical trials			55,054				57,629
Consulting			13,916				8,917
Professional fees			21,241				534,984
Accrued interest			0				143,264
Total accrued expenses		$	126,512			$	913,063

4. Accrued Expenses

Accrued expenses consist of the following:

		December 31,
		2014				2013
Payroll and benefits		$	168,269			$	30,920
Clinical trials			57,629				216,350
Consulting			8,917				12,988
Professional fees			534,984				157,953
Accrued interest			143,264				70,778
Total accrued expenses		$	913,063			$	488,989